In the Editorial titled “Vasopressin and Steroids as Adjunctive Treatment for In-Hospital Cardiac Arrest,” published online in the September 29, 2021, issue of JAMA, there was a factual error regarding the proportion of patients who received targeted temperature management in the VAM-IHCA trial. The sentence that read, “In the VAM-IHCA trial, all patients received targeted temperature management, although several differences existed between study groups during the postresuscitation period” should have read, “In the VAM-IHCA trial, the proportion of patients who received targeted temperature management was comparable in the intervention group (27%) and in the placebo group (26%), although several differences existed between study groups during the postresuscitation period.” This article was corrected online.
Source: JAMA Online First